{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T21:40:18Z","timestamp":1649022018189},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T00:00:00Z","timestamp":1435968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00281-015-0510-8","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T09:25:31Z","timestamp":1435915531000},"page":"565-574","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fibrogenesis, novel lessons from animal models"],"prefix":"10.1007","volume":"37","author":[{"given":"Ellen","family":"De Langhe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik","family":"Lories","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,4]]},"reference":[{"key":"510_CR1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989\u20132003","journal-title":"N Engl J Med"},{"key":"510_CR2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214:199\u2013210","journal-title":"J Pathol"},{"key":"510_CR3","first-page":"1202","volume":"19","author":"O Ishikawa","year":"1992","unstructured":"Ishikawa O, Ishikawa H (1992) Macrophage infiltration in the skin of patients with systemic sclerosis. J Rheumatol 19:1202\u20131206","journal-title":"J Rheumatol"},{"key":"510_CR4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000163933","volume":"63","author":"BM Kraling","year":"1995","unstructured":"Kraling BM, Maul GG, Jimenez SA (1995) Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes\/macrophages. Pathobiology 63:48\u201356","journal-title":"Pathobiology"},{"key":"510_CR5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.autrev.2011.04.019","volume":"10","author":"V Liakouli","year":"2011","unstructured":"Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R (2011) Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 10:590\u2013594","journal-title":"Autoimmun Rev"},{"key":"510_CR6","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.0801414105","volume":"105","author":"R Eferl","year":"2008","unstructured":"Eferl R, Hasselblatt P, Rath M, Popper H, Zenz R, Komnenovic V, Idarraga MH, Kenner L, Wagner EF (2008) Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2\/AP-1. Proc Natl Acad Sci U S A 105:10525\u201310530","journal-title":"Proc Natl Acad Sci U S A"},{"key":"510_CR7","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1161\/CIRCULATIONAHA.109.855114","volume":"120","author":"B Maurer","year":"2009","unstructured":"Maurer B, Busch N, Jungel A, Pileckyte M, Gay RE, Michel BA, Schett G, Gay S, Distler J, Distler O (2009) Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation 120:2367\u20132376","journal-title":"Circulation"},{"key":"510_CR8","doi-asserted-by":"crossref","unstructured":"Maurer B, Reich N, Juengel A, Kriegsmann J, Gay RE, Schett G, Michel BA, Gay S, Distler JH, Distler O (2012) Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis. Ann Rheum Dis 71(8):1382\u20137","DOI":"10.1136\/annrheumdis-2011-200940"},{"key":"510_CR9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/art.38942","volume":"67","author":"P Venalis","year":"2015","unstructured":"Venalis P, Kumanovics G, Schulze-Koops H, Distler A, Dees C, Zerr P, Palumbo-Zerr K, Czirjak L, Mackevic Z, Lundberg IE, Distler O, Schett G, Distler JH (2015) Cardiomyopathy in murine models of systemic sclerosis. Arthritis Rheum 67:508\u2013516","journal-title":"Arthritis Rheum"},{"key":"510_CR10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/annrheumdis-2012-201615","volume":"72","author":"M Kramer","year":"2013","unstructured":"Kramer M, Dees C, Huang J, Schlottmann I, Palumbo-Zerr K, Zerr P, Gelse K, Beyer C, Distler A, Marquez VE, Distler O, Schett G, Distler JH (2013) Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis. Ann Rheum Dis 72:614\u2013620","journal-title":"Ann Rheum Dis"},{"key":"510_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/art.30101","volume":"63","author":"M Manetti","year":"2011","unstructured":"Manetti M, Allanore Y, Revillod L, Fatini C, Guiducci S, Cuomo G, Bonino C, Riccieri V, Bazzichi L, Liakouli V, Cipriani P, Giacomelli R, Abbate R, Bombardieri S, Valesini G, Montecucco C, Valentini G, Ibba-Manneschi L, Matucci-Cerinic M (2011) A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. Arthritis Rheum 63:247\u2013256","journal-title":"Arthritis Rheum"},{"key":"510_CR12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI118489","volume":"97","author":"M Dewerchin","year":"1996","unstructured":"Dewerchin M, Nuffelen AV, Wallays G, Bouche A, Moons L, Carmeliet P, Mulligan RC, Collen D (1996) Generation and characterization of urokinase receptor-deficient mice. J Clin Invest 97:870\u2013878","journal-title":"J Clin Invest"},{"key":"510_CR13","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2013-203706","volume":"73","author":"M Manetti","year":"2014","unstructured":"Manetti M, Rosa I, Milia AF, Guiducci S, Carmeliet P, Ibba-Manneschi L, Matucci-Cerinic M (2014) Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? Ann Rheum Dis 73:1700\u20131709","journal-title":"Ann Rheum Dis"},{"key":"510_CR14","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1073\/pnas.87.4.1332","volume":"87","author":"Y Ben-David","year":"1990","unstructured":"Ben-David Y, Giddens EB, Bernstein A (1990) Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc Natl Acad Sci U S A 87:1332\u20131336","journal-title":"Proc Natl Acad Sci U S A"},{"key":"510_CR15","doi-asserted-by":"crossref","first-page":"20839","DOI":"10.1074\/jbc.M010133200","volume":"276","author":"J Czuwara-Ladykowska","year":"2001","unstructured":"Czuwara-Ladykowska J, Shirasaki F, Jackers P, Watson DK, Trojanowska M (2001) Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem 276:20839\u201320848","journal-title":"J Biol Chem"},{"key":"510_CR16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)63685-1","volume":"163","author":"M Kubo","year":"2003","unstructured":"Kubo M, Czuwara-Ladykowska J, Moussa O, Markiewicz M, Smith E, Silver RM, Jablonska S, Blaszczyk M, Watson DK, Trojanowska M (2003) Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol 163:571\u2013581","journal-title":"Am J Pathol"},{"key":"510_CR17","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","volume":"54","author":"Y Wang","year":"2006","unstructured":"Wang Y, Fan PS, Kahaleh B (2006) Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum 54:2271\u20132279","journal-title":"Arthritis Rheum"},{"key":"510_CR18","doi-asserted-by":"crossref","first-page":"34672","DOI":"10.1074\/jbc.M703907200","volume":"282","author":"Y Asano","year":"2007","unstructured":"Asano Y, Czuwara J, Trojanowska M (2007) Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300\/CREB-binding protein-associated factor-dependent acetylation. J Biol Chem 282:34672\u201334683","journal-title":"J Biol Chem"},{"key":"510_CR19","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1128\/MCB.20.15.5643-5652.2000","volume":"20","author":"DD Spyropoulos","year":"2000","unstructured":"Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, Watson DK (2000) Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 20:5643\u20135652","journal-title":"Mol Cell Biol"},{"key":"510_CR20","first-page":"2167","volume":"8","author":"VN Rao","year":"1993","unstructured":"Rao VN, Ohno T, Prasad DD, Bhattacharya G, Reddy ES (1993) Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein. Oncogene 8:2167\u20132173","journal-title":"Oncogene"},{"key":"510_CR21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/MCB.01278-08","volume":"29","author":"Y Asano","year":"2009","unstructured":"Asano Y, Markiewicz M, Kubo M, Szalai G, Watson DK, Trojanowska M (2009) Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin. Mol Cell Biol 29:425\u2013434","journal-title":"Mol Cell Biol"},{"key":"510_CR22","doi-asserted-by":"crossref","first-page":"25259","DOI":"10.1074\/jbc.M600466200","volume":"281","author":"SS Nakerakanti","year":"2006","unstructured":"Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M (2006) Fli1 and Ets1 have distinct roles in connective tissue growth factor\/CCN2 gene regulation and induction of the profibrotic gene program. J Biol Chem 281:25259\u201325269","journal-title":"J Biol Chem"},{"key":"510_CR23","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","volume":"176","author":"Y Asano","year":"2010","unstructured":"Asano Y, Stawski L, Hant F, Highland K, Silver R, Szalai G, Watson DK, Trojanowska M (2010) Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol 176:1983\u20131998","journal-title":"Am J Pathol"},{"key":"510_CR24","doi-asserted-by":"crossref","first-page":"R309","DOI":"10.1186\/ar1183","volume":"6","author":"Y Allanore","year":"2004","unstructured":"Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A (2004) Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1. Arthritis Res Ther 6:R309\u2013R314","journal-title":"Arthritis Res Ther"},{"key":"510_CR25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","volume":"95","author":"O Distler","year":"2004","unstructured":"Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, Michel BA, Gay RE, Muller-Ladner U, Matucci-Cerinic M, Plate KH, Gassmann M, Gay S (2004) Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 95:109\u2013116","journal-title":"Circ Res"},{"key":"510_CR26","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1136\/annrheumdis-2013-203535","volume":"73","author":"B Maurer","year":"2014","unstructured":"Maurer B, Distler A, Suliman YA, Gay RE, Michel BA, Gay S, Distler JH, Distler O (2014) Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis. Ann Rheum Dis 73:1880\u20131887","journal-title":"Ann Rheum Dis"},{"key":"510_CR27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1523-1747.1999.00476.x","volume":"112","author":"P Sambo","year":"1999","unstructured":"Sambo P, Jannino L, Candela M, Salvi A, Donini M, Dusi S, Luchetti MM, Gabrielli A (1999) Monocytes of patients with systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion. J Invest Dermatol 112:78\u201384","journal-title":"J Invest Dermatol"},{"key":"510_CR28","first-page":"4","volume":"19","author":"AL Herrick","year":"2001","unstructured":"Herrick AL, Matucci CM (2001) The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 19:4\u20138","journal-title":"Clin Exp Rheumatol"},{"key":"510_CR29","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","volume":"182","author":"A Servettaz","year":"2009","unstructured":"Servettaz A, Goulvestre C, Kavian N, Nicco C, Guilpain P, Chereau C, Vuiblet V, Guillevin L, Mouthon L, Weill B, Batteux F (2009) Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol 182:5855\u20135864","journal-title":"J Immunol"},{"key":"510_CR30","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/rheumatology\/ket144","volume":"52","author":"G Bagnato","year":"2013","unstructured":"Bagnato G, Bitto A, Pizzino G, Irrera N, Sangari D, Cinquegrani M, Roberts WN, Matucci Cerinic M, Squadrito F, Altavilla D, Bagnato G, Saitta A (2013) Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis. Rheumatology (Oxford) 52:1377\u20131386","journal-title":"Rheumatology (Oxford)"},{"key":"510_CR31","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/jid.2011.455","volume":"132","author":"WK Marut","year":"2012","unstructured":"Marut WK, Kavian N, Servettaz A, Nicco C, Ba LA, Doering M, Chereau C, Jacob C, Weill B, Batteux F (2012) The organotelluride catalyst (PHTE)(2)NQ prevents HOCl-induced systemic sclerosis in mouse. J Invest Dermatol 132:1125\u20131132","journal-title":"J Invest Dermatol"},{"key":"510_CR32","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/art.34534","volume":"64","author":"N Kavian","year":"2012","unstructured":"Kavian N, Marut W, Servettaz A, Nicco C, Chereau C, Lemarechal H, Borderie D, Dupin N, Weill B, Batteux F (2012) Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis. Arthritis Rheum 64:3430\u20133440","journal-title":"Arthritis Rheum"},{"key":"510_CR33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/BOR.0b013e32834b0dac","volume":"23","author":"L Bon van","year":"2011","unstructured":"van Bon L, Cossu M, Radstake TR (2011) An update on an immune system that goes awry in systemic sclerosis. Curr Opin Rheumatol 23:505\u2013510","journal-title":"Curr Opin Rheumatol"},{"key":"510_CR34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.0022-202X.2005.23767.x","volume":"125","author":"M Horikawa","year":"2005","unstructured":"Horikawa M, Hasegawa M, Komura K, Hayakawa I, Yanaba K, Matsushita T, Takehara K, Sato S (2005) Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity. J Invest Dermatol 125:731\u2013737","journal-title":"J Invest Dermatol"},{"key":"510_CR35","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","volume":"168","author":"LI Sakkas","year":"2002","unstructured":"Sakkas LI, Xu B, Artlett CM, Lu S, Jimenez SA, Platsoucas CD (2002) Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 168:3649\u20133659","journal-title":"J Immunol"},{"key":"510_CR36","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/ard.2009.128207","volume":"69","author":"L Bon van","year":"2010","unstructured":"van Bon L, Popa C, Huijbens R, Vonk M, York M, Simms R, Hesselstrand R, Wuttge DM, Lafyatis R, Radstake TR (2010) Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 69:1539\u20131547","journal-title":"Ann Rheum Dis"},{"key":"510_CR37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","volume":"182","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya S, Kelley K, Melichian DS, Tamaki Z, Fang F, Su Y, Feng G, Pope RM, Budinger GR, Mutlu GM, Lafyatis R, Radstake T, Feghali-Bostwick C, Varga J (2013) Toll-like receptor 4 signaling augments transforming growth factor-beta responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol 182:192\u2013205","journal-title":"Am J Pathol"},{"key":"510_CR38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.38901","volume":"67","author":"T Takahashi","year":"2015","unstructured":"Takahashi T, Asano Y, Ichimura Y, Toyama T, Taniguchi T, Noda S, Akamata K, Tada Y, Sugaya M, Kadono T, Sato S (2015) Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis. Arthritis Rheum 67:254\u2013265","journal-title":"Arthritis Rheum"},{"key":"510_CR39","first-page":"214013","volume":"2011","author":"D Daoussis","year":"2011","unstructured":"Daoussis D, Liossis SN, Yiannopoulos G, Andonopoulos AP (2011) B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence. Int J Rheum 2011:214013","journal-title":"Int J Rheum"},{"key":"510_CR40","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","volume":"100","author":"ML Whitfield","year":"2003","unstructured":"Whitfield ML, Finlay DR, Murray JI, Troyanskaya OG, Chi JT, Pergamenschikov A, McCalmont TH, Brown PO, Botstein D, Connolly MK (2003) Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci U S A 100:12319\u201312324","journal-title":"Proc Natl Acad Sci U S A"},{"key":"510_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.08.003","volume":"56","author":"A Francois","year":"2015","unstructured":"Francois A, Gombault A, Villeret B, Alsaleh G, Fanny M, Gasse P, Adam SM, Crestani B, Sibilia J, Schneider P, Bahram S, Quesniaux V, Ryffel B, Wachsmann D, Gottenberg JE, Couillin I (2015) B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis. J Autoimmun 56:1\u201311","journal-title":"J Autoimmun"},{"key":"510_CR42","first-page":"1751","volume":"151","author":"C Mavalia","year":"1997","unstructured":"Mavalia C, Scaletti C, Romagnani P, Carossino AM, Pignone A, Emmi L, Pupilli C, Pizzolo G, Maggi E, Romagnani S (1997) Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 151:1751\u20131758","journal-title":"Am J Pathol"},{"key":"510_CR43","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/annrheumdis-2012-201759","volume":"72","author":"J Avouac","year":"2013","unstructured":"Avouac J, Elhai M, Tomcik M, Ruiz B, Friese M, Piedavent M, Colonna M, Bernhardt G, Kahan A, Chiocchia G, Distler JH, Allanore Y (2013) Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis. Ann Rheum Dis 72:1089\u20131098","journal-title":"Ann Rheum Dis"},{"key":"510_CR44","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1002\/art.38808","volume":"66","author":"A Perez-Frias","year":"2014","unstructured":"Perez-Frias A, Gonzalez-Tajuelo R, Nunez-Andrade N, Tejedor R, Garcia-Blanco MJ, Vicente-Rabaneda E, Castaneda S, Gamallo C, Silvan J, Esteban-Villafruela A, Cubero-Rueda L, Garcia-Garcia C, Munoz-Calleja C, Garcia-Diez A, Urzainqui A (2014) Development of an autoimmune syndrome affecting the skin and internal organs in P-selectin glycoprotein ligand 1 leukocyte receptor-deficient mice. Arthritis Rheum 66:3178\u20133189","journal-title":"Arthritis Rheum"},{"key":"510_CR45","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776\u20131784","journal-title":"J Clin Invest"},{"key":"510_CR46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/art.38988","volume":"67","author":"GS Bogatkevich","year":"2015","unstructured":"Bogatkevich GS (2015) Editorial: fate of fat tissue adipocytes: do they transform into myofibroblasts in scleroderma? Arthritis Rheum 67:860\u2013861","journal-title":"Arthritis Rheum"},{"key":"510_CR47","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/ard.2010.134742","volume":"70","author":"C Dees","year":"2011","unstructured":"Dees C, Tomcik M, Zerr P, Akhmetshina A, Horn A, Palumbo K, Beyer C, Zwerina J, Distler O, Schett G, Distler JH (2011) Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis. Ann Rheum Dis 70:1304\u20131310","journal-title":"Ann Rheum Dis"},{"key":"510_CR48","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/art.30254","volume":"63","author":"C Dees","year":"2011","unstructured":"Dees C, Zerr P, Tomcik M, Beyer C, Horn A, Akhmetshina A, Palumbo K, Reich N, Zwerina J, Sticherling M, Mattson MP, Distler O, Schett G, Distler JH (2011) Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis. Arthritis Rheum 63:1396\u20131404","journal-title":"Arthritis Rheum"},{"key":"510_CR49","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ajpath.2011.06.001","volume":"179","author":"S Piera-Velazquez","year":"2011","unstructured":"Piera-Velazquez S, Li Z, Jimenez SA (2011) Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 179:1074\u20131080","journal-title":"Am J Pathol"},{"key":"510_CR50","doi-asserted-by":"crossref","first-page":"R1113","DOI":"10.1186\/ar1790","volume":"7","author":"VS Rajkumar","year":"2005","unstructured":"Rajkumar VS, Howell K, Csiszar K, Denton CP, Black CM, Abraham DJ (2005) Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Res Ther 7:R1113\u2013R1123","journal-title":"Arthritis Res Ther"},{"key":"510_CR51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","volume":"1","author":"R Bucala","year":"1994","unstructured":"Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71\u201381","journal-title":"Mol Med"},{"key":"510_CR52","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/art.38276","volume":"66","author":"S Liu","year":"2014","unstructured":"Liu S, Herault Y, Pavlovic G, Leask A (2014) Skin progenitor cells contribute to bleomycin-induced skin fibrosis. Arthritis Rheum 66:707\u2013713","journal-title":"Arthritis Rheum"},{"key":"510_CR53","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","volume":"67","author":"RG Marangoni","year":"2015","unstructured":"Marangoni RG, Korman BD, Wei J, Wood TA, Graham LV, Whitfield ML, Scherer PE, Tourtellotte WG, Varga J (2015) Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors. Arthritis Rheum 67:1062\u20131073","journal-title":"Arthritis Rheum"},{"key":"510_CR54","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/ncomms1734","volume":"3","author":"A Akhmetshina","year":"2012","unstructured":"Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, Schneider H, Sadowski A, Riener MO, MacDougald OA, Distler O, Schett G, Distler JH (2012) Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun 3:735","journal-title":"Nat Commun"},{"key":"510_CR55","doi-asserted-by":"crossref","unstructured":"Horn A, Kireva T, Palumbo-Zerr K, Dees C, Tomcik M, Cordazzo C, Zerr P, Akhmetshina A, Ruat M, Distler O, Beyer C, Schett G, Distler JH (2012) Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis. Ann Rheum Dis 71(5):785\u2013789","DOI":"10.1136\/annrheumdis-2011-200883"},{"key":"510_CR56","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R (2012) Wnt\/beta-Catenin signaling and disease. Cell 149:1192\u20131205","journal-title":"Cell"},{"key":"510_CR57","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/annrheumdis-2011-200568","volume":"71","author":"C Beyer","year":"2012","unstructured":"Beyer C, Schramm A, Akhmetshina A, Dees C, Kireva T, Gelse K, Sonnylal S, de Crombrugghe B, Taketo MM, Distler O, Schett G, Distler JH (2012) Beta-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis. Ann Rheum Dis 71:761\u2013767","journal-title":"Ann Rheum Dis"},{"key":"510_CR58","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1165\/rcmb.2010-0113OC","volume":"45","author":"AP Lam","year":"2011","unstructured":"Lam AP, Flozak AS, Russell S, Wei J, Jain M, Mutlu GM, Budinger GR, Feghali-Bostwick CA, Varga J, Gottardi CJ (2011) Nuclear beta-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation. Am J Respir Cell Mol Biol 45:915\u2013922","journal-title":"Am J Respir Cell Mol Biol"},{"key":"510_CR59","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/annrheumdis-2012-202544","volume":"72","author":"C Beyer","year":"2013","unstructured":"Beyer C, Reichert H, Akan H, Mallano T, Schramm A, Dees C, Palumbo-Zerr K, Lin NY, Distler A, Gelse K, Varga J, Distler O, Schett G, Distler JH (2013) Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis. Ann Rheum Dis 72:1255\u20131258","journal-title":"Ann Rheum Dis"},{"key":"510_CR60","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1136\/ard.2010.147140","volume":"70","author":"C Bergmann","year":"2011","unstructured":"Bergmann C, Akhmetshina A, Dees C, Palumbo K, Zerr P, Beyer C, Zwerina J, Distler O, Schett G, Distler JH (2011) Inhibition of glycogen synthase kinase 3 beta induces dermal fibrosis by activation of the canonical Wnt pathway. Ann Rheum Dis 70:2191\u20132198","journal-title":"Ann Rheum Dis"},{"key":"510_CR61","doi-asserted-by":"crossref","first-page":"14309","DOI":"10.1073\/pnas.1001520107","volume":"107","author":"WR Henderson Jr","year":"2010","unstructured":"Henderson WR Jr, Chi EY, Ye X, Nguyen C, Tien YT, Zhou B, Borok Z, Knight DA, Kahn M (2010) Inhibition of Wnt\/beta-catenin\/CREB binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci U S A 107:14309\u201314314","journal-title":"Proc Natl Acad Sci U S A"},{"key":"510_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-012-1304-7","volume":"305","author":"C Beyer","year":"2013","unstructured":"Beyer C, Dees C, Distler JH (2013) Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis. Arch Dermatol Res 305:1\u20138","journal-title":"Arch Dermatol Res"},{"key":"510_CR63","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1755-1536-7-14","volume":"7","author":"E Langhe De","year":"2014","unstructured":"De Langhe E, Aznar-Lopez C, De Vooght V, Vanoirbeek JA, Luyten FP, Lories RJ (2014) Secreted frizzled related proteins inhibit fibrosis in vitro but appear redundant in vivo. Fibrogenesis Tissue Repair 7:14","journal-title":"Fibrogenesis Tissue Repair"},{"key":"510_CR64","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/art.30312","volume":"63","author":"J Wei","year":"2011","unstructured":"Wei J, Melichian D, Komura K, Hinchcliff M, Lam AP, Lafyatis R, Gottardi CJ, MacDougald OA, Varga J (2011) Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum 63:1707\u20131717","journal-title":"Arthritis Rheum"},{"key":"510_CR65","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/annrheumdis-2012-202275","volume":"72","author":"A Distler","year":"2013","unstructured":"Distler A, Deloch L, Huang J, Dees C, Lin NY, Palumbo-Zerr K, Beyer C, Weidemann A, Distler O, Schett G, Distler JH (2013) Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling. Ann Rheum Dis 72:1575\u20131580","journal-title":"Ann Rheum Dis"},{"key":"510_CR66","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/annrheumdis-2012-203194","volume":"73","author":"C Dees","year":"2014","unstructured":"Dees C, Schlottmann I, Funke R, Distler A, Palumbo-Zerr K, Zerr P, Lin NY, Beyer C, Distler O, Schett G, Distler JH (2014) The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis. Ann Rheum Dis 73:1232\u20131239","journal-title":"Ann Rheum Dis"},{"key":"510_CR67","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/annrheumdis-2013-203995","volume":"73","author":"A Distler","year":"2014","unstructured":"Distler A, Ziemer C, Beyer C, Lin NY, Chen CW, Palumbo-Zerr K, Dees C, Weidemann A, Distler O, Schett G, Distler JH (2014) Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling. Ann Rheum Dis 73:624\u2013627","journal-title":"Ann Rheum Dis"},{"key":"510_CR68","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/art.37907","volume":"65","author":"J Vorstenbosch","year":"2013","unstructured":"Vorstenbosch J, Al-Ajmi H, Winocour S, Trzeciak A, Lessard L, Philip A (2013) CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma. Arthritis Rheum 65:1378\u20131383","journal-title":"Arthritis Rheum"},{"key":"510_CR69","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1183\/09031936.00090614","volume":"45","author":"LJ Rubin","year":"2015","unstructured":"Rubin LJ, Galie N, Grimminger F, Grunig E, Humbert M, Jing ZC, Keogh A, Langleben D, Fritsch A, Menezes F, Davie N, Ghofrani HA (2015) Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2). Eur Respir J 45:1303\u20131313","journal-title":"Eur Respir J"},{"key":"510_CR70","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","volume":"369","author":"HA Ghofrani","year":"2013","unstructured":"Ghofrani HA, Galie N, Grimminger F, Grunig E, Humbert M, Jing ZC, Keogh AM, Langleben D, Kilama MO, Fritsch A, Neuser D, Rubin LJ, Group P-S (2013) Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med 369:330\u2013340","journal-title":"N Engl J Med"},{"key":"510_CR71","author":"C Beyer","year":"2014","unstructured":"Beyer C, Zenzmaier C, Palumbo-Zerr K, Mancuso R, Distler A, Dees C, Zerr P, Huang J, Maier C, Pachowsky ML, Friebe A, Sandner P, Distler O, Schett G, Berger P, Distler JH (2014) Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFbeta signalling. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2013-204508","journal-title":"Ann Rheum Dis"},{"key":"510_CR72","doi-asserted-by":"crossref","unstructured":"Dees C, Beyer C, Distler A, Soare A, Zhang Y, Palumbo-Zerr K, Distler O, Schett G, Sandner P, Distler JH (2015) Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2014-206809","DOI":"10.1136\/annrheumdis-2014-206809"},{"key":"510_CR73","doi-asserted-by":"crossref","unstructured":"Huang J, Beyer C, Palumbo-Zerr K, Zhang Y, Ramming A, Distler A, Gelse K, Distler O, Schett G, Wollin L, Distler JH (2015) Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis. Ann Rheum Dis doi: 10.1136\/annrheumdis-2014-207109","DOI":"10.1136\/annrheumdis-2014-207109"},{"key":"510_CR74","author":"M Tomcik","year":"2015","unstructured":"Tomcik M, Palumbo-Zerr K, Zerr P, Sumova B, Avouac J, Dees C, Distler A, Becvar R, Distler O, Schett G, Senolt L, Distler JH (2015) Tribbles homologue 3 stimulates canonical TGF-beta signalling to regulate fibroblast activation and tissue fibrosis. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2014-206234","journal-title":"Ann Rheum Dis"},{"key":"510_CR75","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/annrheumdis-2012-203095","volume":"73","author":"M Tomcik","year":"2014","unstructured":"Tomcik M, Zerr P, Pitkowski J, Palumbo-Zerr K, Avouac J, Distler O, Becvar R, Senolt L, Schett G, Distler JH (2014) Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-beta signalling to prevent fibrosis. Ann Rheum Dis 73:1215\u20131222","journal-title":"Ann Rheum Dis"},{"key":"510_CR76","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20101629","volume":"208","author":"C Dees","year":"2011","unstructured":"Dees C, Akhmetshina A, Zerr P, Reich N, Palumbo K, Horn A, Jungel A, Beyer C, Kronke G, Zwerina J, Reiter R, Alenina N, Maroteaux L, Gay S, Schett G, Distler O, Distler JH (2011) Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med 208:961\u2013972","journal-title":"J Exp Med"},{"key":"510_CR77","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1002\/art.27642","volume":"62","author":"S Marquart","year":"2010","unstructured":"Marquart S, Zerr P, Akhmetshina A, Palumbo K, Reich N, Tomcik M, Horn A, Dees C, Engel M, Zwerina J, Distler O, Schett G, Distler JH (2010) Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis. Arthritis Rheum 62:3467\u20133476","journal-title":"Arthritis Rheum"},{"key":"510_CR78","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1172\/JCI200419603","volume":"114","author":"CE Daniels","year":"2004","unstructured":"Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, Leof EB (2004) Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest 114:1308\u20131316","journal-title":"J Clin Invest"},{"key":"510_CR79","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/art.34500","volume":"64","author":"C Dees","year":"2012","unstructured":"Dees C, Tomcik M, Palumbo-Zerr K, Distler A, Beyer C, Lang V, Horn A, Zerr P, Zwerina J, Gelse K, Distler O, Schett G, Distler JH (2012) JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor beta in systemic sclerosis. Arthritis Rheum 64:3006\u20133015","journal-title":"Arthritis Rheum"},{"key":"510_CR80","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/annrheumdis-2011-200412","volume":"71","author":"N Reich","year":"2012","unstructured":"Reich N, Tomcik M, Zerr P, Lang V, Dees C, Avouac J, Palumbo K, Horn A, Akhmetshina A, Beyer C, Xie W, Bennett BL, Distler O, Schett G, Distler JH (2012) Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosis. Ann Rheum Dis 71:737\u2013745","journal-title":"Ann Rheum Dis"},{"key":"510_CR81","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/art.27636","volume":"62","author":"JR Seibold","year":"2010","unstructured":"Seibold JR, Denton CP, Furst DE, Guillevin L, Rubin LJ, Wells A, Matucci Cerinic M, Riemekasten G, Emery P, Chadha-Boreham H, Charef P, Roux S, Black CM (2010) Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. Arthritis Rheum 62:2101\u20132108","journal-title":"Arthritis Rheum"},{"key":"510_CR82","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/rccm.200906-0964OC","volume":"181","author":"CE Daniels","year":"2010","unstructured":"Daniels CE, Lasky JA, Limper AH, Mieras K, Gabor E, Schroeder DR (2010) Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results. Am J Respir Crit Care Med 181:604\u2013610","journal-title":"Am J Respir Crit Care Med"},{"key":"510_CR83","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1136\/annrheumdis-2013-203729","volume":"72","author":"B Maurer","year":"2013","unstructured":"Maurer B, Distler A, Dees C, Khan K, Denton CP, Abraham D, Gay RE, Michel BA, Gay S, Hw Distler J, Distler O (2013) Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors. Ann Rheum Dis 72:2039\u20132046","journal-title":"Ann Rheum Dis"},{"key":"510_CR84","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/annrheumdis-2013-204221","volume":"73","author":"A Distler","year":"2014","unstructured":"Distler A, Lang V, Del Vecchio T, Huang J, Zhang Y, Beyer C, Lin NY, Palumbo-Zerr K, Distler O, Schett G, Distler JH (2014) Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability. Ann Rheum Dis 73:1264\u20131268","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0510-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-015-0510-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0510-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T23:20:43Z","timestamp":1566948043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-015-0510-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,4]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["510"],"URL":"https:\/\/doi.org\/10.1007\/s00281-015-0510-8","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,4]]}}}